ROLE OF COMMUNITY PARAMEDICINE IN NON-EMERGENCY PRESENTATIONS
Dr Robbie King
Lecturer in paramedicine and researcher, Australian Catholic University (ACU) Brisbane &
Senior Advanced Care Paramedic/Community Paramedic,
Sunshine Coast District, Birtinya Station,
Queensland Ambulance Service, Australia
RESEARCHER PROFILE
Filmed in Brisbane, Queensland | November 2024
Dr Robbie King is a Lecturer in paramedicine and researcher at the Australian Catholic University (ACU) Brisbane. He also continues to provide clinical care as a registered paramedic for community members served by a jurisdictional ambulance service. Dr King has gained significant experience working in an advanced practice, community paramedic style role, holding expert clinical insight into the nuances of paramedic-led community-based healthcare for non-emergency presentations. This often involves adopting a biopsychosocial approach, rather than following the biomedical model more associated with emergency medicine and paramedic culture.
To encourage a patient-centred approach to paramedic-led healthcare by exploring the unmet needs of people requesting unscheduled emergency ambulance care, Dr King advocates for greater consumer engagement in paramedic research. He completed his PhD in early 2024 which explored the patient perspective of paramedic-led healthcare when patients were not transported to hospital. This research generated a theory that describes a process of patients ‘restoring self-efficacy’ when their vulnerabilities are validated, and they receive clinically competent and compassionate care.
Dr King has presented at professional symposium internationally, and in Australia where he continues to encourage greater consumer involvement in research to inform development of paramedic education and ambulance service models of healthcare delivery. Dr King is a Fellow of the Australasian College of Paramedicine and member of various professional research and Community Paramedic working groups. His research focus includes exploring the role of community paramedics in improving health literacy, self-efficacy, and addressing the psychosocial needs of patients requesting emergency ambulance services.
-
New treatments for patients with mental illness
Associate Professor Bernadette Fitzgibbon is a neuroscientist with several decades of experience in researching, developing, and translating novel therapies for mental health and chronic pain conditions. This includes the application and optimisation of brain stimulation and psychedelic therapies, overseeing large multi-site intervention trials, both within Australia and abroad. Through her work, she has developed meaningful collaborations with consumers, volunteers, policy makers, and services providers, ensuring that the outcomes of her work contribute towards real-world clinical impact.
-
Funding the best brains to beat brain cancer
The Charlie Teo Foundation is dedicated to funding and advancing research into brain cancer, with a particular focus on developing more effective treatments and finding a cure for this devastating disease.
Since its inception, the foundation has committed nearly $15 million to brain cancer research, funding notable projects in Australia and the United States. These projects explore innovative approaches to understand and treat brain cancer more effectively, with a focus on translating findings from animal studies to human applications. Charlie’s dedication to finding solutions for this devastating disease remains unwavering as he travels frequently to collaborate with global researchers. -
At the frontier of human cellular neuroscience research
Associate Professor Cedric Bardy is the Director of The Laboratory for Human Neurophysiology, Genetics & Stem Cells, located at SAHMRI. South Australia.
His current research uses preclinical, patient-derived cell models to test innovative therapeutic strategies, with a current focus on Parkinson’s disease, brain cancer and childhood dementia (Sanfilippo syndrome).
His work has established a platform to facilitate the discovery and validation of treatments for brain disorders. Their research is at the frontier of human cellular neuroscience research and translational applications that benefit global public health.
